Immunology

Browse venture capital firms focused on Immunology.

Explore VC firms that invest in Immunology. Filter by country and stage to refine results.

4 of 1354 firms
Filters:
Agent Capital favicon
Agent Capital
United States

Agent Capital is a healthcare venture capital firm focused on novel technologies and therapeutics that address unmet patient need.

Founded 2017
Investment Stages
Seed
Series A
Series B
Series C
Markets
Rare Diseases
Oncology
Neurology
Immunology
Artis Ventures favicon
Artis Ventures
United States

Artis Ventures is a venture capital firm focused on investments at the convergence of frontier technologies and medicine. They invest in data-driven life sciences companies creating scalable medical technologies with broad healthcare applications. Their focus is on creating global impact through engineering-first approaches and flexible investment strategies.

Founded 2001
Investment Stages
Seed
Series A
Series B
Markets
Oncology
Immunology
Cardiopulmonary + Metabolic
Multi + Other
Neurology + Mental Health
Aging
Infectious
Women's Health
Synthetic & Computation Biology
Clinical Medicine
Consumer Health
Data & Compute
Internet of TechBio (IoTB)
Sanofi Ventures favicon
Sanofi Ventures
United States, France

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.

Founded 2001
Investment Stages
Seed
Series A
Series B
Markets
Biotherapeutic
Digital Health
Rare diseases
Immunology and inflammation
Oncology
Cell and gene therapy
Vaccines
Data science
Syncona favicon
Syncona
United Kingdom, Guernsey

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.

Founded 2012
Investment Stages
Series A
Series B
Series C
Markets
Oncology
Ophthalmology
Cell therapy
Gene therapy
Renal
Cardioprotection
Immunology
Rare diseases